By Scott Power
03 September 2021, 9:00 AM
Ebos Group (ASX:EBO) has added to its medical consumables portfolio, with the well flagged acquisition of a medical consumables business.
Read more...
By Dr Derek Jellinek
25 August 2021, 7:30 AM
FY21 was in line with guidance, albeit below our expectations, with record organic sales and underlying earnings growth driven via unprecedented PPE demand.
Read more...
By Dr Derek Jellinek
24 August 2021, 9:00 AM
FY21 underlying results were in line with consensus expectations, albeit above our estimates, with COVID testing driving upside across all laboratory businesses.
Read more...
By Scott Power
24 August 2021, 7:00 AM
Mach7 Technologies (ASX:M7T) posted an in-line result for FY21. The highlights included a record sales order book and further R&D spend (28% of revenue) into new product development.
Read more...
By Dr Derek Jellinek
23 August 2021, 10:00 AM
FY21 results were inline with our estimates, albeit below consensus, with double-digit earnings and sales growth driven by market share gains/growth, and rescheduled surgeries from COVID shutdowns across key regions.
Read more...
By Scott Power
19 August 2021, 12:00 PM
Ebos Group (ASX:EBO) posted a strong FY21 result in line with our forecasts, with the highest recorded ROCE (18.0%) reflected by double digit earnings growth.
Read more...
By Dr Derek Jellinek
19 August 2021, 10:30 AM
FY21 results were solid, with better than expected top/bottom line growth and improving OCF, but GM contracted on higher plasma costs.
Read more...
By Iain Wilkie
19 August 2021, 10:00 AM
Pro Medicus (ASX:PME) recorded another year of strong growth across all metrics although lower than our forecasts and consensus expectations.
Read more...
By Scott Power
18 August 2021, 1:00 PM
Ebos Group (ASX:EBO) posted a strong FY21 result in line with our forecasts, with the highest recorded ROCE (18.0%) reflected by double digit earnings growth.
Read more...
By Scott Power
10 August 2021, 9:30 AM
The Morgans Healthcare Team provides a preview of the upcoming reporting season, highlighting their key stock picks.
Read more...